With 10-year Treasury yields near 5%, three Dividend Kings—Johnson & Johnson, Procter & Gamble, and Altria—stand out by raising dividends for over 50 consecutive years while maintaining low market volatility (low beta). These companies generate strong cash flow to cover dividends, providing growing income that fixed-rate bonds cannot match in a rising rate environment. J&J offers a AAA credit rating and strong balance sheet, P&G boasts the longest dividend increase streak and robust free cash flow, and Altria provides the highest yield with pricing power despite industry volume challenges. Their mix of safety, yield, and dividend growth makes them attractive for investors seeking protection against rising interest rates.
The article highlights Dividend Kings like Johnson & Johnson and Procter & Gamble as strong dividend payers in a rising rate environment. On Pluang as of Oct 19, 2026 21:02 WIB, Johnson & Johnson trades at USD 253.85 with a dividend yield of 2.1%, while Procter & Gamble is priced at USD 158.23 with a dividend yield of 2.73%. Both stocks show slight declines of around 0.67% in one day, reflecting typical short-term market movements.
Johnson & Johnson announced that TREMFYA (guselkumab) maintained or improved fistula remission in adults with Crohn's disease through 48 weeks in the Phase 3 FUZION study. The combined fistula remission rate increased from 28% at Week 24 to 35% at We...
Johnson & Johnson reported a solid quarter with 6% sales growth and strong oncology business expansion, despite a slight miss in MedTech. Analysts maintain a bullish outlook with a 12-month price target of $291.60, implying a 15.6% upside from curren...
Jim Cramer and financial analysts recommend investors diversify portfolios with stable, dividend-paying stocks like consumer staples, pharmaceuticals, and waste management to protect against tech sector downturns. These 'quiet winners' continue to de...
Johnson & Johnson's recent quarterly report showed its MedTech segment sales fell short of Wall Street expectations, primarily due to pricing pressures in China and budget cuts in Europe. This shortfall caused the company's shares to decline, impacti...
